NervGen Pharma Corp.
NervGen Pharma Corp. (NGENF) Stock Competitors & Peer Comparison
See (NGENF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NGENF | $3.95 | -2.47% | 312.9M | -15.19 | -$0.26 | N/A |
| NONOF | $43.40 | +3.01% | 193.3B | 12.05 | $3.61 | +4.19% |
| CSLLY | $22.40 | -0.58% | 86.7B | 14.55 | $1.54 | +3.26% |
| UCBJY | $135.12 | +0.69% | 51.4B | 28.72 | $4.70 | N/A |
| UCBJF | $269.84 | -1.61% | 51.4B | 28.71 | $9.40 | N/A |
| ARGNF | $724.55 | +0.00% | 44.8B | 37.04 | $19.56 | N/A |
| CMXHF | $89.96 | +3.59% | 43.7B | 14.58 | $6.17 | +3.25% |
| WXIBF | $4.70 | +0.00% | 19.4B | 27.65 | $0.17 | N/A |
| IVBXF | $11.25 | +1.56% | 19.4B | 160.71 | $0.07 | N/A |
| WXXWY | $8.55 | +1.03% | 17.4B | 24.80 | $0.34 | N/A |
Stock Comparison
NGENF vs NONOF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, NONOF has a market cap of 193.3B. Regarding current trading prices, NGENF is priced at $3.95, while NONOF trades at $43.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas NONOF's P/E ratio is 12.05. In terms of profitability, NGENF's ROE is -974.60%, compared to NONOF's ROE of +0.61%. Regarding short-term risk, NGENF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check NONOF's competition here
NGENF vs CSLLY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CSLLY has a market cap of 86.7B. Regarding current trading prices, NGENF is priced at $3.95, while CSLLY trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CSLLY's P/E ratio is 14.55. In terms of profitability, NGENF's ROE is -974.60%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, NGENF is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CSLLY's competition here
NGENF vs UCBJY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, UCBJY has a market cap of 51.4B. Regarding current trading prices, NGENF is priced at $3.95, while UCBJY trades at $135.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas UCBJY's P/E ratio is 28.72. In terms of profitability, NGENF's ROE is -974.60%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, NGENF is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check UCBJY's competition here
NGENF vs UCBJF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, UCBJF has a market cap of 51.4B. Regarding current trading prices, NGENF is priced at $3.95, while UCBJF trades at $269.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas UCBJF's P/E ratio is 28.71. In terms of profitability, NGENF's ROE is -974.60%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, NGENF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check UCBJF's competition here
NGENF vs ARGNF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ARGNF has a market cap of 44.8B. Regarding current trading prices, NGENF is priced at $3.95, while ARGNF trades at $724.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ARGNF's P/E ratio is 37.04. In terms of profitability, NGENF's ROE is -974.60%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, NGENF is less volatile compared to ARGNF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check ARGNF's competition here
NGENF vs CMXHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CMXHF has a market cap of 43.7B. Regarding current trading prices, NGENF is priced at $3.95, while CMXHF trades at $89.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CMXHF's P/E ratio is 14.58. In terms of profitability, NGENF's ROE is -974.60%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, NGENF is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CMXHF's competition here
NGENF vs WXIBF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, WXIBF has a market cap of 19.4B. Regarding current trading prices, NGENF is priced at $3.95, while WXIBF trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas WXIBF's P/E ratio is 27.65. In terms of profitability, NGENF's ROE is -974.60%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, NGENF is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check WXIBF's competition here
NGENF vs IVBXF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, IVBXF has a market cap of 19.4B. Regarding current trading prices, NGENF is priced at $3.95, while IVBXF trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas IVBXF's P/E ratio is 160.71. In terms of profitability, NGENF's ROE is -974.60%, compared to IVBXF's ROE of +0.05%. Regarding short-term risk, NGENF is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IVBXF's competition here
NGENF vs WXXWY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, WXXWY has a market cap of 17.4B. Regarding current trading prices, NGENF is priced at $3.95, while WXXWY trades at $8.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas WXXWY's P/E ratio is 24.80. In terms of profitability, NGENF's ROE is -974.60%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, NGENF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check WXXWY's competition here
NGENF vs GNMSF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, GNMSF has a market cap of 16.3B. Regarding current trading prices, NGENF is priced at $3.95, while GNMSF trades at $265.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas GNMSF's P/E ratio is 17.25. In terms of profitability, NGENF's ROE is -974.60%, compared to GNMSF's ROE of +0.19%. Regarding short-term risk, NGENF is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GNMSF's competition here
NGENF vs SBMFF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SBMFF has a market cap of 13.6B. Regarding current trading prices, NGENF is priced at $3.95, while SBMFF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SBMFF's P/E ratio is 25.33. In terms of profitability, NGENF's ROE is -974.60%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, NGENF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SBMFF's competition here
NGENF vs SBHMY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SBHMY has a market cap of 12.8B. Regarding current trading prices, NGENF is priced at $3.95, while SBHMY trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, NGENF's ROE is -974.60%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, NGENF is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SBHMY's competition here
NGENF vs BRRGF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, NGENF is priced at $3.95, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, NGENF's ROE is -974.60%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, NGENF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BRRGF's competition here
NGENF vs AAVXF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, NGENF is priced at $3.95, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, NGENF's ROE is -974.60%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, NGENF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check AAVXF's competition here
NGENF vs ODTC Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, NGENF is priced at $3.95, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ODTC's P/E ratio is 1.07. In terms of profitability, NGENF's ROE is -974.60%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, NGENF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ODTC's competition here
NGENF vs AKBLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, AKBLF has a market cap of 7.2B. Regarding current trading prices, NGENF is priced at $3.95, while AKBLF trades at $35.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas AKBLF's P/E ratio is 41.83. In terms of profitability, NGENF's ROE is -974.60%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, NGENF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check AKBLF's competition here
NGENF vs TRSBF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, TRSBF has a market cap of 6.7B. Regarding current trading prices, NGENF is priced at $3.95, while TRSBF trades at $2.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas TRSBF's P/E ratio is 20.18. In terms of profitability, NGENF's ROE is -974.60%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, NGENF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check TRSBF's competition here
NGENF vs REGMF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, REGMF has a market cap of 6.2B. Regarding current trading prices, NGENF is priced at $3.95, while REGMF trades at $10.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas REGMF's P/E ratio is 57.63. In terms of profitability, NGENF's ROE is -974.60%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, NGENF is less volatile compared to REGMF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check REGMF's competition here
NGENF vs ABCZF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, NGENF is priced at $3.95, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, NGENF's ROE is -974.60%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, NGENF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ABCZF's competition here
NGENF vs LABFF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, NGENF is priced at $3.95, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas LABFF's P/E ratio is 28.95. In terms of profitability, NGENF's ROE is -974.60%, compared to LABFF's ROE of +0.23%. Regarding short-term risk, NGENF is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check LABFF's competition here
NGENF vs SHJBF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SHJBF has a market cap of 4.3B. Regarding current trading prices, NGENF is priced at $3.95, while SHJBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SHJBF's P/E ratio is -25.00. In terms of profitability, NGENF's ROE is -974.60%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, NGENF is more volatile compared to SHJBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SHJBF's competition here
NGENF vs CAMRF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CAMRF has a market cap of 3.8B. Regarding current trading prices, NGENF is priced at $3.95, while CAMRF trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CAMRF's P/E ratio is 47.59. In terms of profitability, NGENF's ROE is -974.60%, compared to CAMRF's ROE of +0.19%. Regarding short-term risk, NGENF is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CAMRF's competition here
NGENF vs TLPPF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, TLPPF has a market cap of 3.6B. Regarding current trading prices, NGENF is priced at $3.95, while TLPPF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas TLPPF's P/E ratio is -525.00. In terms of profitability, NGENF's ROE is -974.60%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, NGENF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check TLPPF's competition here
NGENF vs ZLDPF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ZLDPF has a market cap of 3.3B. Regarding current trading prices, NGENF is priced at $3.95, while ZLDPF trades at $47.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ZLDPF's P/E ratio is 3.35. In terms of profitability, NGENF's ROE is -974.60%, compared to ZLDPF's ROE of +0.48%. Regarding short-term risk, NGENF is less volatile compared to ZLDPF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check ZLDPF's competition here
NGENF vs ASPHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ASPHF has a market cap of 3.2B. Regarding current trading prices, NGENF is priced at $3.95, while ASPHF trades at $8.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ASPHF's P/E ratio is -16.00. In terms of profitability, NGENF's ROE is -974.60%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, NGENF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ASPHF's competition here
NGENF vs GNNSF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, GNNSF has a market cap of 3.1B. Regarding current trading prices, NGENF is priced at $3.95, while GNNSF trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas GNNSF's P/E ratio is -5.68. In terms of profitability, NGENF's ROE is -974.60%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, NGENF is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GNNSF's competition here
NGENF vs BRCTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, NGENF is priced at $3.95, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BRCTF's P/E ratio is 26.42. In terms of profitability, NGENF's ROE is -974.60%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, NGENF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BRCTF's competition here
NGENF vs MPSYF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, NGENF is priced at $3.95, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, NGENF's ROE is -974.60%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, NGENF is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MPSYF's competition here
NGENF vs BVNKF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BVNKF has a market cap of 2.4B. Regarding current trading prices, NGENF is priced at $3.95, while BVNKF trades at $30.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BVNKF's P/E ratio is 11.13. In terms of profitability, NGENF's ROE is -974.60%, compared to BVNKF's ROE of +0.11%. Regarding short-term risk, NGENF is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BVNKF's competition here
NGENF vs INCPF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, NGENF is priced at $3.95, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas INCPF's P/E ratio is 25.83. In terms of profitability, NGENF's ROE is -974.60%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, NGENF is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check INCPF's competition here
NGENF vs BVNRY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, NGENF is priced at $3.95, while BVNRY trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BVNRY's P/E ratio is 10.72. In terms of profitability, NGENF's ROE is -974.60%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, NGENF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BVNRY's competition here
NGENF vs ASCLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ASCLF has a market cap of 2.3B. Regarding current trading prices, NGENF is priced at $3.95, while ASCLF trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ASCLF's P/E ratio is -43.00. In terms of profitability, NGENF's ROE is -974.60%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, NGENF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ASCLF's competition here
NGENF vs GENSF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, NGENF is priced at $3.95, while GENSF trades at $33.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas GENSF's P/E ratio is 34.54. In terms of profitability, NGENF's ROE is -974.60%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, NGENF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check GENSF's competition here
NGENF vs MEOBF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, NGENF is priced at $3.95, while MEOBF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, NGENF's ROE is -974.60%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, NGENF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MEOBF's competition here
NGENF vs GLPGF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, NGENF is priced at $3.95, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, NGENF's ROE is -974.60%, compared to GLPGF's ROE of +0.11%. Regarding short-term risk, NGENF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GLPGF's competition here
NGENF vs PHMMF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, NGENF is priced at $3.95, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, NGENF's ROE is -974.60%, compared to PHMMF's ROE of +0.35%. Regarding short-term risk, NGENF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PHMMF's competition here
NGENF vs ONTTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, NGENF is priced at $3.95, while ONTTF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ONTTF's P/E ratio is -8.75. In terms of profitability, NGENF's ROE is -974.60%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, NGENF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check ONTTF's competition here
NGENF vs CSPHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, NGENF is priced at $3.95, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, NGENF's ROE is -974.60%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, NGENF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CSPHF's competition here
NGENF vs BIESF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, NGENF is priced at $3.95, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BIESF's P/E ratio is -44.44. In terms of profitability, NGENF's ROE is -974.60%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, NGENF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BIESF's competition here
NGENF vs HBMHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, NGENF is priced at $3.95, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas HBMHF's P/E ratio is 17.33. In terms of profitability, NGENF's ROE is -974.60%, compared to HBMHF's ROE of +0.36%. Regarding short-term risk, NGENF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check HBMHF's competition here
NGENF vs SNBIF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, NGENF is priced at $3.95, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, NGENF's ROE is -974.60%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, NGENF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check SNBIF's competition here
NGENF vs PHGUF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, PHGUF has a market cap of 1.2B. Regarding current trading prices, NGENF is priced at $3.95, while PHGUF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas PHGUF's P/E ratio is -175.00. In terms of profitability, NGENF's ROE is -974.60%, compared to PHGUF's ROE of +0.01%. Regarding short-term risk, NGENF is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PHGUF's competition here
NGENF vs MDCLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, NGENF is priced at $3.95, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, NGENF's ROE is -974.60%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, NGENF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MDCLF's competition here
NGENF vs NURPF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, NGENF is priced at $3.95, while NURPF trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas NURPF's P/E ratio is 51.91. In terms of profitability, NGENF's ROE is -974.60%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, NGENF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check NURPF's competition here
NGENF vs CSBTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CSBTF has a market cap of 1.1B. Regarding current trading prices, NGENF is priced at $3.95, while CSBTF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CSBTF's P/E ratio is 350.00. In terms of profitability, NGENF's ROE is -974.60%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, NGENF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CSBTF's competition here
NGENF vs IDRSF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, IDRSF has a market cap of 1.1B. Regarding current trading prices, NGENF is priced at $3.95, while IDRSF trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas IDRSF's P/E ratio is -3.30. In terms of profitability, NGENF's ROE is -974.60%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, NGENF is more volatile compared to IDRSF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IDRSF's competition here
NGENF vs BTTAY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, NGENF is priced at $3.95, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, NGENF's ROE is -974.60%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, NGENF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BTTAY's competition here
NGENF vs PPTDF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, PPTDF has a market cap of 934.2M. Regarding current trading prices, NGENF is priced at $3.95, while PPTDF trades at $7.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas PPTDF's P/E ratio is -40.17. In terms of profitability, NGENF's ROE is -974.60%, compared to PPTDF's ROE of -0.03%. Regarding short-term risk, NGENF is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check PPTDF's competition here
NGENF vs TKBIF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, NGENF is priced at $3.95, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas TKBIF's P/E ratio is -22.12. In terms of profitability, NGENF's ROE is -974.60%, compared to TKBIF's ROE of N/A. Regarding short-term risk, NGENF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check TKBIF's competition here
NGENF vs BPMUF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BPMUF has a market cap of 846.9M. Regarding current trading prices, NGENF is priced at $3.95, while BPMUF trades at $69.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BPMUF's P/E ratio is 9.69. In terms of profitability, NGENF's ROE is -974.60%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, NGENF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check BPMUF's competition here
NGENF vs IVEVF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, NGENF is priced at $3.95, while IVEVF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas IVEVF's P/E ratio is -2.40. In terms of profitability, NGENF's ROE is -974.60%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, NGENF is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IVEVF's competition here
NGENF vs VBIZF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, VBIZF has a market cap of 725M. Regarding current trading prices, NGENF is priced at $3.95, while VBIZF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas VBIZF's P/E ratio is 34.34. In terms of profitability, NGENF's ROE is -974.60%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, NGENF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check VBIZF's competition here
NGENF vs SOLTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SOLTF has a market cap of 605.4M. Regarding current trading prices, NGENF is priced at $3.95, while SOLTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SOLTF's P/E ratio is -7.69. In terms of profitability, NGENF's ROE is -974.60%, compared to SOLTF's ROE of -0.19%. Regarding short-term risk, NGENF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check SOLTF's competition here
NGENF vs CKDXF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, NGENF is priced at $3.95, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, NGENF's ROE is -974.60%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, NGENF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CKDXF's competition here
NGENF vs INRLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, INRLF has a market cap of 542.1M. Regarding current trading prices, NGENF is priced at $3.95, while INRLF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas INRLF's P/E ratio is -3.94. In terms of profitability, NGENF's ROE is -974.60%, compared to INRLF's ROE of -0.75%. Regarding short-term risk, NGENF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check INRLF's competition here
NGENF vs GNFTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, NGENF is priced at $3.95, while GNFTF trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas GNFTF's P/E ratio is -4.69. In terms of profitability, NGENF's ROE is -974.60%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, NGENF is more volatile compared to GNFTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GNFTF's competition here
NGENF vs PTCHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, PTCHF has a market cap of 467.4M. Regarding current trading prices, NGENF is priced at $3.95, while PTCHF trades at $1.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas PTCHF's P/E ratio is -4.17. In terms of profitability, NGENF's ROE is -974.60%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, NGENF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check PTCHF's competition here
NGENF vs RAONF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, NGENF is priced at $3.95, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas RAONF's P/E ratio is -43.33. In terms of profitability, NGENF's ROE is -974.60%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, NGENF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check RAONF's competition here
NGENF vs GNFTY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, NGENF is priced at $3.95, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, NGENF's ROE is -974.60%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, NGENF is more volatile compared to GNFTY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check GNFTY's competition here
NGENF vs TBGNF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, NGENF is priced at $3.95, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, NGENF's ROE is -974.60%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, NGENF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check TBGNF's competition here
NGENF vs AVCTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, AVCTF has a market cap of 425M. Regarding current trading prices, NGENF is priced at $3.95, while AVCTF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas AVCTF's P/E ratio is -6.48. In terms of profitability, NGENF's ROE is -974.60%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, NGENF is more volatile compared to AVCTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check AVCTF's competition here
NGENF vs CYDY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CYDY has a market cap of 408.2M. Regarding current trading prices, NGENF is priced at $3.95, while CYDY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CYDY's P/E ratio is -7.47. In terms of profitability, NGENF's ROE is -974.60%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, NGENF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CYDY's competition here
NGENF vs NWPHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, NWPHF has a market cap of 399.3M. Regarding current trading prices, NGENF is priced at $3.95, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas NWPHF's P/E ratio is N/A. In terms of profitability, NGENF's ROE is -974.60%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, NGENF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check NWPHF's competition here
NGENF vs SLNCF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SLNCF has a market cap of 334.4M. Regarding current trading prices, NGENF is priced at $3.95, while SLNCF trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SLNCF's P/E ratio is -3.75. In terms of profitability, NGENF's ROE is -974.60%, compared to SLNCF's ROE of -3.59%. Regarding short-term risk, NGENF is more volatile compared to SLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SLNCF's competition here
NGENF vs SPHDF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SPHDF has a market cap of 330.6M. Regarding current trading prices, NGENF is priced at $3.95, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SPHDF's P/E ratio is -4.83. In terms of profitability, NGENF's ROE is -974.60%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, NGENF is more volatile compared to SPHDF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SPHDF's competition here
NGENF vs NWBO Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, NWBO has a market cap of 321.2M. Regarding current trading prices, NGENF is priced at $3.95, while NWBO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas NWBO's P/E ratio is -5.00. In terms of profitability, NGENF's ROE is -974.60%, compared to NWBO's ROE of +0.71%. Regarding short-term risk, NGENF is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check NWBO's competition here
NGENF vs CLVLY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CLVLY has a market cap of 318.1M. Regarding current trading prices, NGENF is priced at $3.95, while CLVLY trades at $6.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CLVLY's P/E ratio is 13.72. In terms of profitability, NGENF's ROE is -974.60%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, NGENF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CLVLY's competition here
NGENF vs CLVLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CLVLF has a market cap of 316.1M. Regarding current trading prices, NGENF is priced at $3.95, while CLVLF trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CLVLF's P/E ratio is 12.54. In terms of profitability, NGENF's ROE is -974.60%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, NGENF is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CLVLF's competition here
NGENF vs FGHQF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, NGENF is priced at $3.95, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, NGENF's ROE is -974.60%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, NGENF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check FGHQF's competition here
NGENF vs PBBIF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, NGENF is priced at $3.95, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, NGENF's ROE is -974.60%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, NGENF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PBBIF's competition here
NGENF vs ORPOF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, NGENF is priced at $3.95, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, NGENF's ROE is -974.60%, compared to ORPOF's ROE of N/A. Regarding short-term risk, NGENF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ORPOF's competition here
NGENF vs ORYZF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, NGENF is priced at $3.95, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, NGENF's ROE is -974.60%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, NGENF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check ORYZF's competition here
NGENF vs HLOSF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, HLOSF has a market cap of 247.6M. Regarding current trading prices, NGENF is priced at $3.95, while HLOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas HLOSF's P/E ratio is -13.53. In terms of profitability, NGENF's ROE is -974.60%, compared to HLOSF's ROE of -0.80%. Regarding short-term risk, NGENF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check HLOSF's competition here
NGENF vs HNSBF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, NGENF is priced at $3.95, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas HNSBF's P/E ratio is -3.37. In terms of profitability, NGENF's ROE is -974.60%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, NGENF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check HNSBF's competition here
NGENF vs CMVLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, NGENF is priced at $3.95, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, NGENF's ROE is -974.60%, compared to CMVLF's ROE of -0.70%. Regarding short-term risk, NGENF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check CMVLF's competition here
NGENF vs CAIHF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, CAIHF has a market cap of 217.4M. Regarding current trading prices, NGENF is priced at $3.95, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas CAIHF's P/E ratio is 2.80. In terms of profitability, NGENF's ROE is -974.60%, compared to CAIHF's ROE of +0.12%. Regarding short-term risk, NGENF is less volatile compared to CAIHF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check CAIHF's competition here
NGENF vs BOVNF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, NGENF is priced at $3.95, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, NGENF's ROE is -974.60%, compared to BOVNF's ROE of -0.47%. Regarding short-term risk, NGENF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BOVNF's competition here
NGENF vs SPHRY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SPHRY has a market cap of 211.7M. Regarding current trading prices, NGENF is priced at $3.95, while SPHRY trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SPHRY's P/E ratio is -83.83. In terms of profitability, NGENF's ROE is -974.60%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, NGENF is more volatile compared to SPHRY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SPHRY's competition here
NGENF vs FPHAF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, NGENF is priced at $3.95, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, NGENF's ROE is -974.60%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, NGENF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check FPHAF's competition here
NGENF vs SCNLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SCNLF has a market cap of 176.3M. Regarding current trading prices, NGENF is priced at $3.95, while SCNLF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SCNLF's P/E ratio is -16.99. In terms of profitability, NGENF's ROE is -974.60%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, NGENF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check SCNLF's competition here
NGENF vs KNTPF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, KNTPF has a market cap of 172.3M. Regarding current trading prices, NGENF is priced at $3.95, while KNTPF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas KNTPF's P/E ratio is -6.12. In terms of profitability, NGENF's ROE is -974.60%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, NGENF is less volatile compared to KNTPF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check KNTPF's competition here
NGENF vs ADOCY Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, NGENF is priced at $3.95, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, NGENF's ROE is -974.60%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, NGENF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ADOCY's competition here
NGENF vs BBIXF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, NGENF is priced at $3.95, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, NGENF's ROE is -974.60%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, NGENF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BBIXF's competition here
NGENF vs SPHRF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, SPHRF has a market cap of 147.3M. Regarding current trading prices, NGENF is priced at $3.95, while SPHRF trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas SPHRF's P/E ratio is -35.00. In terms of profitability, NGENF's ROE is -974.60%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, NGENF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check SPHRF's competition here
NGENF vs AMGXF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, NGENF is priced at $3.95, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, NGENF's ROE is -974.60%, compared to AMGXF's ROE of -0.45%. Regarding short-term risk, NGENF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check AMGXF's competition here
NGENF vs IPHYF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, IPHYF has a market cap of 140.7M. Regarding current trading prices, NGENF is priced at $3.95, while IPHYF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas IPHYF's P/E ratio is -2.31. In terms of profitability, NGENF's ROE is -974.60%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, NGENF is more volatile compared to IPHYF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check IPHYF's competition here
NGENF vs BRIBF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, NGENF is priced at $3.95, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, NGENF's ROE is -974.60%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, NGENF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check BRIBF's competition here
NGENF vs HBPCF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, NGENF is priced at $3.95, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, NGENF's ROE is -974.60%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, NGENF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check HBPCF's competition here
NGENF vs AAPGV Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, NGENF is priced at $3.95, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas AAPGV's P/E ratio is N/A. In terms of profitability, NGENF's ROE is -974.60%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, NGENF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check AAPGV's competition here
NGENF vs TRGNF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, NGENF is priced at $3.95, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas TRGNF's P/E ratio is -2.58. In terms of profitability, NGENF's ROE is -974.60%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, NGENF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check TRGNF's competition here
NGENF vs PSTTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, NGENF is priced at $3.95, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, NGENF's ROE is -974.60%, compared to PSTTF's ROE of N/A. Regarding short-term risk, NGENF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check PSTTF's competition here
NGENF vs JWCTF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, JWCTF has a market cap of 116.6M. Regarding current trading prices, NGENF is priced at $3.95, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, NGENF's ROE is -974.60%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, NGENF is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check JWCTF's competition here
NGENF vs EPRXF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, NGENF is priced at $3.95, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, NGENF's ROE is -974.60%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, NGENF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check EPRXF's competition here
NGENF vs ADOIF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, NGENF is priced at $3.95, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, NGENF's ROE is -974.60%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, NGENF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check ADOIF's competition here
NGENF vs MSCLF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, NGENF is priced at $3.95, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, NGENF's ROE is -974.60%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, NGENF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check MSCLF's competition here
NGENF vs MLLCF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, MLLCF has a market cap of 95.4M. Regarding current trading prices, NGENF is priced at $3.95, while MLLCF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas MLLCF's P/E ratio is -1.21. In terms of profitability, NGENF's ROE is -974.60%, compared to MLLCF's ROE of -0.60%. Regarding short-term risk, NGENF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check MLLCF's competition here
NGENF vs NDTP Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, NDTP has a market cap of 94.9M. Regarding current trading prices, NGENF is priced at $3.95, while NDTP trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas NDTP's P/E ratio is -2.47. In terms of profitability, NGENF's ROE is -974.60%, compared to NDTP's ROE of -0.33%. Regarding short-term risk, NGENF is more volatile compared to NDTP. This indicates potentially higher risk in terms of short-term price fluctuations for NGENF.Check NDTP's competition here
NGENF vs MCURF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, NGENF is priced at $3.95, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas MCURF's P/E ratio is -16.90. In terms of profitability, NGENF's ROE is -974.60%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, NGENF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check MCURF's competition here
NGENF vs RECEF Comparison May 2026
NGENF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NGENF stands at 312.9M. In comparison, RECEF has a market cap of 80.4M. Regarding current trading prices, NGENF is priced at $3.95, while RECEF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NGENF currently has a P/E ratio of -15.19, whereas RECEF's P/E ratio is -3.67. In terms of profitability, NGENF's ROE is -974.60%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, NGENF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for NGENF.Check RECEF's competition here